MétaCan
Menu
Back to cohort
Record W4409627106 · doi:10.1158/1538-7445.am2025-3828

Abstract 3828: Understanding the molecular underpinnings of breast cancer brain metastases: implications for early detection and treatment

2025· article· en· W4409627106 on OpenAlexaff
Melanie Spears, Megan Hopkins, Rania Chehade, Ítalo Fernandes, Vida Talebian, Jane Bayani, Katarzyna J. Jerzak

Bibliographic record

VenueCancer Research · 2025
Typearticle
Languageen
FieldMedicine
TopicBrain Metastases and Treatment
Canadian institutionsSunnybrook Health Science CentreOntario Institute for Cancer Research
Fundersnot available
KeywordsBreast cancerCancerMedicineOncologyInternal medicine

Abstract

fetched live from OpenAlex

Abstract Brain metastases (BrM) are a major cause of morbidity and mortality among patients with metastatic breast cancer. Women with metastatic HER2-positive (HER2+) and triple-negative breast cancer (TNBC) have a particularly high propensity to develop BrM, with up to half developing BrM during their lifetime. Currently, apart from assignment of risk by breast cancer subtype, risk factors for the development of BrM are lacking. Given that BrM are associated with a poor prognosis, particularly among patients with TNBC, there is a critical need for biomarkers to identify patients at high risk of BrM for whom future screening and/or prevention strategies can be employed. In this study we performed whole transcriptomic profiling of 53 brain metastases in triplicate with spatial resolution using Bruker’s Digital Spatial Profiler, Whole Transcriptome Assay. Patients with breast cancer BrM who were treated with surgery, whole brain radiotherapy (WBRT) and/or stereotactic radiosurgery (SRS) between 2008 and 2018 were selected, representative sections of tumor were cored and microarrayed prior to spatial transcriptomic profiling of the tumor and tumor microenvironment. Across both HER2+ and TNBC subtypes, spatial deconvolution revealed a high proportion of CD4+ and CD8+ naïve T-cells in the tumor compartments compared to the tumor microenvironment whereas macrophages were the most abundant immune cell type irrespective of subtype in the tumor microenvironment. Differential gene expression analysis demonstrated that higher expression levels of known HER2 mediated genes including MED1, STARD3 and GRB7 were present in the HER2+ brain subtypes. Markers for stem cell features were more prevalent within tumor compartments of TNBC BrM compared to HER2+ BrM. In conclusion, this study characterized the tumor and tumor microenvironment of breast cancer BrM using spatial transcriptomics, identifying molecular underpinnings that may be targeted for BrM prevention and/or treatment. Citation Format: Melanie Spears, Megan Hopkins, Rania Chehade, Italo Fernandes, Vida Talebian, Jane Bayani, Katarzyna Jerzak. Understanding the molecular underpinnings of breast cancer brain metastases: implications for early detection and treatment [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 3828.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.007

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0020.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.133
GPT teacher head0.451
Teacher spread0.318 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueCancer ResearchSame topicBrain Metastases and TreatmentFrench-language works237,207